"Symbol","AssetType","Name","Description","Exchange","Currency","Country","Sector","Industry","Address","FullTimeEmployees","FiscalYearEnd","LatestQuarter","MarketCapitalization","EBITDA","PERatio","PEGRatio","BookValue","DividendPerShare","DividendYield","EPS","RevenuePerShareTTM","ProfitMargin","OperatingMarginTTM","ReturnOnAssetsTTM","ReturnOnEquityTTM","RevenueTTM","GrossProfitTTM","DilutedEPSTTM","QuarterlyEarningsGrowthYOY","QuarterlyRevenueGrowthYOY","AnalystTargetPrice","TrailingPE","ForwardPE","PriceToSalesRatioTTM","PriceToBookRatio","EVToRevenue","EVToEBITDA","Beta","52WeekHigh","52WeekLow","50DayMovingAverage","200DayMovingAverage","SharesOutstanding","SharesFloat","SharesShort","SharesShortPriorMonth","ShortRatio","ShortPercentOutstanding","ShortPercentFloat","PercentInsiders","PercentInstitutions","ForwardAnnualDividendRate","ForwardAnnualDividendYield","PayoutRatio","DividendDate","ExDividendDate","LastSplitFactor","LastSplitDate"
"AGTC","Common Stock","Applied Genetic Technologies Corporation","Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and three preclinical programs in targeting central nervous system disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, and adrenoleukodystrophy. It has collaboration agreements with Synpromics Limited; University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.","NASDAQ","USD","USA","Healthcare","Biotechnology","14193 NW 119th Terrace, Alachua, FL, United States, 32615","83","June","2020-09-30","224666416","-3077000","None","0","2.173","None","0","-0.11","0.107","0","-20.3889","-0.3672","-0.8004","2453000","-13933000","-2.16","0","-1","15.81","0","0","36.9481","1.815","20.4823","0","2.2433","7.4","2.29","4.4748","5.0031","42631200","21576155","1025692","1068549","4.7","0.04","0.0398","1.023","68.319","0","0","0","None","None","None","None"
